Thrivent Financial for Lutherans’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $6.39M | Sell |
29,210
-14,656
| -33% | -$3.21M | 0.01% | 724 |
|
2025
Q1 | $9.82M | Buy |
43,866
+33,243
| +313% | +$7.44M | 0.02% | 618 |
|
2024
Q4 | $3.48M | Sell |
10,623
-8,115
| -43% | -$2.66M | 0.01% | 1094 |
|
2024
Q3 | $5.63M | Buy |
18,738
+7,334
| +64% | +$2.2M | 0.01% | 877 |
|
2024
Q2 | $3.76M | Sell |
11,404
-3,544
| -24% | -$1.17M | 0.01% | 1016 |
|
2024
Q1 | $5.92M | Sell |
14,948
-57
| -0.4% | -$22.6K | 0.01% | 824 |
|
2023
Q4 | $5.28M | Sell |
15,005
-910
| -6% | -$320K | 0.01% | 832 |
|
2023
Q3 | $5.97M | Buy |
15,915
+2,007
| +14% | +$753K | 0.01% | 747 |
|
2023
Q2 | $5.32M | Buy |
13,908
+10,594
| +320% | +$4.05M | 0.01% | 831 |
|
2023
Q1 | $1.15M | Buy |
3,314
+7
| +0.2% | +$2.43K | ﹤0.01% | 1696 |
|
2022
Q4 | $778K | Buy |
3,307
+13
| +0.4% | +$3.06K | ﹤0.01% | 1891 |
|
2022
Q3 | $811K | Sell |
3,294
-1,557
| -32% | -$383K | ﹤0.01% | 1813 |
|
2022
Q2 | $1.47M | Sell |
4,851
-121
| -2% | -$36.6K | ﹤0.01% | 1441 |
|
2022
Q1 | $2.04M | Sell |
4,972
-10,247
| -67% | -$4.21M | ﹤0.01% | 1312 |
|
2021
Q4 | $6.97M | Buy |
15,219
+10,454
| +219% | +$4.79M | 0.01% | 790 |
|
2021
Q3 | $2.02M | Buy |
4,765
+23
| +0.5% | +$9.77K | ﹤0.01% | 1342 |
|
2021
Q2 | $1.7M | Sell |
4,742
-1,038
| -18% | -$373K | ﹤0.01% | 1520 |
|
2021
Q1 | $1.63M | Sell |
5,780
-38,856
| -87% | -$10.9M | ﹤0.01% | 1545 |
|
2020
Q4 | $12.6M | Buy |
44,636
+36,364
| +440% | +$10.3M | 0.03% | 574 |
|
2020
Q3 | $2.27M | Sell |
8,272
-186
| -2% | -$51.1K | 0.01% | 1082 |
|
2020
Q2 | $1.92M | Sell |
8,458
-38,991
| -82% | -$8.86M | 0.01% | 1086 |
|
2020
Q1 | $7.22M | Sell |
47,449
-23,559
| -33% | -$3.59M | 0.03% | 576 |
|
2019
Q4 | $10.7M | Buy |
71,008
+30,736
| +76% | +$4.62M | 0.03% | 546 |
|
2019
Q3 | $5.71M | Sell |
40,272
-79,834
| -66% | -$11.3M | 0.02% | 657 |
|
2019
Q2 | $15M | Sell |
120,106
-42,362
| -26% | -$5.3M | 0.05% | 404 |
|
2019
Q1 | $17.9M | Buy |
162,468
+972
| +0.6% | +$107K | 0.06% | 347 |
|
2018
Q4 | $15.8M | Buy |
161,496
+15,857
| +11% | +$1.55M | 0.06% | 342 |
|
2018
Q3 | $18M | Buy |
145,639
+6,037
| +4% | +$745K | 0.06% | 350 |
|
2018
Q2 | $13.9M | Buy |
139,602
+1,582
| +1% | +$157K | 0.05% | 405 |
|
2018
Q1 | $12.2M | Buy |
138,020
+916
| +0.7% | +$80.9K | 0.04% | 416 |
|
2017
Q4 | $13.5M | Sell |
137,104
-114
| -0.1% | -$11.2K | 0.05% | 379 |
|
2017
Q3 | $13.2M | Buy |
137,218
+820
| +0.6% | +$78.9K | 0.05% | 350 |
|
2017
Q2 | $12.9M | Buy |
136,398
+1,230
| +0.9% | +$116K | 0.05% | 325 |
|
2017
Q1 | $11M | Buy |
135,168
+1,180
| +0.9% | +$96.3K | 0.05% | 360 |
|
2016
Q4 | $11.4M | Sell |
133,988
-44,670
| -25% | -$3.79M | 0.05% | 344 |
|
2016
Q3 | $13.3M | Sell |
178,658
-11,080
| -6% | -$825K | 0.06% | 310 |
|
2016
Q2 | $14.4M | Sell |
189,738
-26,760
| -12% | -$2.03M | 0.07% | 280 |
|
2016
Q1 | $15M | Buy |
216,498
+62,490
| +41% | +$4.33M | 0.07% | 257 |
|
2015
Q4 | $9.27M | Buy |
154,008
+96,340
| +167% | +$5.8M | 0.04% | 366 |
|
2015
Q3 | $3.12M | Buy |
57,668
+29,668
| +106% | +$1.61M | 0.02% | 681 |
|
2015
Q2 | $1.63M | Buy |
28,000
+1,500
| +6% | +$87.1K | 0.01% | 713 |
|
2015
Q1 | $1.6M | Buy |
26,500
+700
| +3% | +$42.2K | 0.01% | 734 |
|
2014
Q4 | $1.37M | Buy |
25,800
+50
| +0.2% | +$2.66K | 0.01% | 778 |
|
2014
Q3 | $1.15M | Sell |
25,750
-100
| -0.4% | -$4.48K | 0.01% | 830 |
|
2014
Q2 | $1.09M | Buy |
25,850
+350
| +1% | +$14.8K | 0.01% | 856 |
|
2014
Q1 | $1.12M | Hold |
25,500
| – | – | 0.01% | 697 |
|
2013
Q4 | $1.25M | Buy |
25,500
+300
| +1% | +$14.7K | 0.01% | 709 |
|
2013
Q3 | $1.04M | Hold |
25,200
| – | – | 0.01% | 716 |
|
2013
Q2 | $885 | Buy |
+25,200
| New | +$885 | 0.01% | 729 |
|